AR antagonist (Eikon Therapeutics)

N/A

Report date: 2025/06/11 10:30:47
NME

Base Information

Drug NameAR antagonist (Eikon Therapeutics)
Drug Alias Nameandrogen receptor antagonist (Eikon Therapeutics)
ClassificationSmall molecules
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEikon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEikon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A